Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

EPO anticorps (AA 34-192)

Cet anticorps anti-EPO est un anticorps Lapin Polyclonal détectant EPO dans WB. Adapté pour Souris et Rat.
N° du produit ABIN5693048

Aperçu rapide pour EPO anticorps (AA 34-192) (ABIN5693048)

Antigène

Voir toutes EPO Anticorps
EPO (Erythropoietin (EPO))

Reactivité

  • 155
  • 31
  • 25
  • 7
  • 6
  • 5
  • 5
  • 4
  • 4
  • 2
  • 1
  • 1
  • 1
  • 1
Souris, Rat

Hôte

  • 118
  • 75
  • 6
  • 2
  • 1
Lapin

Clonalité

  • 112
  • 90
Polyclonal

Conjugué

  • 112
  • 18
  • 12
  • 7
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp EPO est non-conjugé

Application

  • 128
  • 87
  • 67
  • 44
  • 32
  • 28
  • 25
  • 20
  • 13
  • 13
  • 11
  • 8
  • 8
  • 5
  • 4
  • 4
  • 4
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
Western Blotting (WB)
  • Épitope

    • 46
    • 16
    • 15
    • 11
    • 10
    • 6
    • 5
    • 5
    • 4
    • 4
    • 3
    • 3
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 34-192

    Fonction

    Anti-EPO Antibody Picoband®

    Réactivité croisée (Details)

    No cross-reactivity with other proteins.

    Attributs du produit

    Anti-EPO Antibody Picoband® (ABIN5693048). Tested in WB applications. This antibody reacts with Mouse, Rat. The brand Picoband indicates this is a premium antibody that guarantees superior quality, high affinity, and strong signals with minimal background in Western blot applications. Only our best-performing antibodies are designated as Picoband, ensuring unmatched performance.

    Immunogène

    E. coli-derived mouse EPO recombinant protein (Position: D34-R192).

    Isotype

    IgG
  • Indications d'application

    Western blot, 0.1-0.5 μg/mL
    1. Hosseini-Zare MS, Dashti-Khavidaki S, Mahdavi-Mazdeh M, Ahmadi F, Akrami S (2012). "Peripheral neuropathy response to erythropoietin in type 2 diabetic patients with mild to moderate renal failure". Clinical Neurology and Neurosurgery. 114 (6): 663-7. 2. Middleton SA, Barbone FP, Johnson DL, Thurmond RL, You Y, McMahon FJ, Jin R, Livnah O, Tullai J, Farrell FX, Goldsmith MA, Wilson IA, Jolliffe LK (1999). "Shared and unique determinants of the erythropoietin (EPO) receptor are important for binding EPO and EPO mimetic peptide". The Journal of Biological Chemistry. 274 (20): 14163-9.

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Add 0.2 mL of distilled water will yield a concentration of 500 μg/mL.

    Concentration

    500 μg/mL

    Buffer

    Each vial contains 4 mg Trehalose, 0.9 mg NaCl, 0.2 mg Na2HPO4, 0.05 mg NaN3.

    Agent conservateur

    Sodium azide

    Précaution d'utilisation

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Stock

    4 °C,-20 °C

    Stockage commentaire

    Store at -20°C for one year from date of receipt. After reconstitution, at 4°C for one month.
    It can also be aliquotted and stored frozen at -20°C for six months. Avoid repeated freeze-thaw cycles.
  • Antigène

    EPO (Erythropoietin (EPO))

    Autre désignation

    Epo

    Classe de substances

    Hormone

    Sujet

    Synonyms: Erythropoietin, Epo

    Tissue Specificity: Produced by kidney or liver of adult mammals and by liver of fetal or neonatal mammals.

    Background: This EPO gene encodes a secreted, glycosylated cytokine composed of four alpha helical bundles. The encoded protein is mainly synthesized in the kidney, secreted into the blood plasma, and binds to the erythropoietin receptor to promote red blood cell production, or erythropoiesis, in the bone marrow. Expression of this gene is upregulated under hypoxic conditions, in turn leading to increased erythropoiesis and enhanced oxygen-carrying capacity of the blood. Expression of this gene has also been observed in brain and in the eye, and elevated expression levels have been observed in diabetic retinopathy and ocular hypertension. Recombinant forms of the encoded protein exhibit neuroprotective activity against a variety of potential brain injuries, as well as antiapoptotic functions in several tissue types, and have been used in the treatment of anemia and to enhance the efficacy of cancer therapies.

    Poids moléculaire

    28 kDa

    ID gène

    13856

    UniProt

    P07321

    Pathways

    Signalistation JAK/STAT, Hormone Activity, Negative Regulation of intrinsic apoptotic Signaling, Negative Regulation of Transporter Activity
Vous êtes ici:
Chat with us!